ACHV - Achieve issues update on cytisinicline development program May, 14 2020 08:11 AM Achieve Life Sciences Inc. Achieve Life Sciences (NASDAQ:ACHV) provides an update on the cytisinicline clinical development program.More news on: Achieve Life Sciences, Inc., Healthcare stocks news, Read more ...